These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 3006228)

  • 1. Acyclovir prophylaxis in bone marrow transplant recipients.
    Lundgren G; Wilczek H; Lönnqvist B; Lindholm A; Wahren B; Ringdén O
    Scand J Infect Dis Suppl; 1985; 47():137-44. PubMed ID: 3006228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of herpes simplex virus (HSV) infection in recipients of HLA-matched T-lymphocyte-depleted bone marrow allografts.
    Engelhard D; Morag A; Or R; Naparstek E; Cividalli G; Ruchlemer R; Aker M; Maayan S; Slavin S
    Isr J Med Sci; 1988 Mar; 24(3):145-50. PubMed ID: 3286577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term acyclovir prophylaxis in bone marrow transplant recipients and lymphocyte proliferation responses to herpes virus antigens in vitro.
    Ljungman P; Wilczek H; Gahrton G; Gustavsson A; Lundgren G; Lönnqvist B; Ringdén O; Wahren B
    Bone Marrow Transplant; 1986 Dec; 1(2):185-92. PubMed ID: 2844333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acyclovir and renal transplantation.
    Pettersson E; Eklund B; Höckerstedt K; Salmela K; Ahonen J
    Scand J Infect Dis Suppl; 1985; 47():145-8. PubMed ID: 3912970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acyclovir prophylaxis of herpes-simplex-virus infections.
    Saral R; Burns WH; Laskin OL; Santos GW; Lietman PS
    N Engl J Med; 1981 Jul; 305(2):63-7. PubMed ID: 6264292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies in the prophylaxis of herpes infections in severely immunocompromised patients using acyclovir.
    Prentice HG; Hann IM
    Schweiz Med Wochenschr Suppl; 1983; 14():26-9. PubMed ID: 6361988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing varicella zoster virus infection after allogeneic peripheral blood stem cell transplantation: low-dose acyclovir prophylaxis and pre-transplant diagnosis of lymphoproliferative disorders.
    Kim DH; Messner H; Minden M; Gupta V; Kuruvilla J; Wright J; Lipton J
    Transpl Infect Dis; 2008 Apr; 10(2):90-8. PubMed ID: 17605742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of herpes zoster in patients by long-term oral acyclovir after allogeneic bone marrow transplantation.
    Perren TJ; Powles RL; Easton D; Stolle K; Selby PJ
    Am J Med; 1988 Aug; 85(2A):99-101. PubMed ID: 3044103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention and therapy of herpesvirus infections].
    Abb J
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):107-20. PubMed ID: 2986378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts.
    Balfour HH; Chace BA; Stapleton JT; Simmons RL; Fryd DS
    N Engl J Med; 1989 May; 320(21):1381-7. PubMed ID: 2541335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy.
    Eisen D; Essell J; Broun ER; Sigmund D; DeVoe M
    Bone Marrow Transplant; 2003 Jan; 31(1):51-5. PubMed ID: 12621507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Varicella zoster infection after bone marrow transplantation: incidence, risk factors and complications.
    Han CS; Miller W; Haake R; Weisdorf D
    Bone Marrow Transplant; 1994 Mar; 13(3):277-83. PubMed ID: 8199570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized clinical trial of ganciclovir vs acyclovir for prevention of cytomegalovirus antigenemia after allogeneic transplantation.
    Burns LJ; Miller W; Kandaswamy C; DeFor TE; MacMillan ML; Van Burik JA; Weisdorf DJ
    Bone Marrow Transplant; 2002 Dec; 30(12):945-51. PubMed ID: 12476289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose oral acyclovir for prevention of herpes simplex virus infection during OKT3 therapy.
    Tang IY; Maddux MS; Veremis SA; Bauma WD; Pollak R; Mozes MF
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1758-60. PubMed ID: 2652575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients. Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Reusser P; Cordonnier C; Einsele H; Engelhard D; Link D; Locasciulli A; Ljungman P
    Bone Marrow Transplant; 1996 May; 17(5):813-7. PubMed ID: 8733703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of acyclovir for prophylaxis of herpes infections in severely immunocompromised patients.
    Prentice HG
    J Antimicrob Chemother; 1983 Sep; 12 Suppl B():153-9. PubMed ID: 6313594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival in allogeneic bone marrow transplant recipients following acyclovir prophylaxis for CMV infection. The European Acyclovir for CMV Prophylaxis Study Group.
    Prentice HG; Gluckman E; Powles RL; Ljungman P; Milpied NJ; Camara R; Mandelli F; Kho P; Kennedy L; Bell AR
    Bone Marrow Transplant; 1997 Jan; 19(2):129-33. PubMed ID: 9116609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience.
    Lamparelli T; Van Lint MT; Gualandi F; Occhini D; Barbanti M; Sacchi N; Ficai G; Ghinatti C; Ferrara GB; Delfino L; Pozzi S; Morabito A; Zikos P; Vitale V; Corvo R; Frassoni F; Bacigalupo A
    Bone Marrow Transplant; 1997 Dec; 20(12):1057-62. PubMed ID: 9466278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial.
    Hann IM; Prentice HG; Blacklock HA; Ross MG; Brigden D; Rosling AE; Burke C; Crawford DH; Brumfitt W; Hoffbrand AV
    Br Med J (Clin Res Ed); 1983 Aug; 287(6389):384-8. PubMed ID: 6307464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant reduction of cytomegalovirus (CMV) disease by prophylaxis with CMV hyperimmune globulin plus oral acyclovir.
    Einsele H; Vallbracht A; Friese M; Schmidt H; Haen M; Dopfer R; Niethammer D; Waller HD; Ehninger G
    Bone Marrow Transplant; 1988 Nov; 3(6):607-17. PubMed ID: 2850830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.